Pharma-Biotech Dominates New England's $19.6 Billion of Projects Under Construction

Pharma-Biotech Dominates New England's $19.6 Billion of Projects Under Construction

Pharma-Biotech Dominates New England


Attachment: New England Projects

July 6, 2022--Researched by Industrial Info Resources (Sugar Land, Texas)--The New England market region, which includes Connecticut, Massachusetts, Maine, New Hampshire, Rhode Island and Vermont, has long been a hotspot for the Pharmaceutical-Biotech Industry and continues to hold this status. Of the more than $19.6 billion in industrial projects under construction in the region, Pharma-Biotech accounts for more than $10.4 billion worth. This is followed by the Industrial Manufacturing and Power industries.

Companies featured: Bristol-Meyers Squibb Company (NYSE:BMY), General Dynamics Corporation (NYSE:GD), Jacobs Engineering Incorporated (NYSE:J), Entergy Corporation (NYSE:ETR)

Subscribe Now!(All Fields Required)

Subscription Type:

  • Pay-Per-Article - $5.95
  • Annual Premium News Subscription - $365.00
Pricing Help?